Solvotrin Therapeutics Competitors and Similar CompaniesClear all

Solvotrin Therapeutics's competitors and similar companies include Livzon Pharmaceutical Group, Alembic Pharmaceuticals, EMS Pharma and UCB.
Solvotrin Therapeutics
Solvotrin Therapeutics
Solvotrin Therapeutics is a drug development company focused on chemical modifications of known drugs.
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
Alembic Pharmaceuticals
Alembic Pharmaceuticals
Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
EMS Pharma
EMS Pharma
EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date
Founding Date
2009
Founding Date
1985
Founding Date
1907
Founding Date
1964
Founding Date
1928
Type
Type
Private
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
IE HQ
Locations
Zhuhai, CN HQ
Chengdu, CN
Qingyuan, CN
Shanghai, CN
Shaoguan, CN
Shenzhen, CN
Zhuhai, CN
Locations
Vadodara, IN HQ
Baska, IN
Mumbai, IN
Namthang, IN
Vadodara, IN
Vadodara, IN
Locations
BR HQ
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Employees
Employees
21
Employees
8,933
Employees
14,8582% increase
Employees
12,2145% decrease
Employees
9,000
Valuation ($)
Valuation ($)
N/A
Valuation ($)
4.2 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
34.3 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
¥12.2b (FY, 2023)
Revenue (est.)
₹61.1b (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
€4.9b (FY, 2023)
Cost of goods
Cost of goods
N/A
Cost of goods
¥4.5b (FY, 2023)
Cost of goods
₹19.3b (FY, 2024)
Cost of goods
N/A
Cost of goods
€1b (FY, 2023)
Gross profit
Gross profit
N/A
Gross profit
¥7.8b (FY, 2023)
Gross profit
₹43b (FY, 2024)
Gross profit
N/A
Gross profit
€4.8b (FY, 2023)
Net income
Net income
N/A
Net income
¥1.9b (FY, 2023)
Net income
₹6.2b (FY, 2024)
Net income
N/A
Net income
€343m (FY, 2023)
For sources of this data, please see the company profile

View Company Profiles

Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
8,933

Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.

View company
Alembic Pharmaceuticals
HQ
Vadodara, IN
Employees
14,858↑ 2% increase

Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates

View company
EMS Pharma
HQ
BR
Employees
12,214↓ 5% decrease

EMS Pharma is a company that specializes in the research, development, and manufacturing of pharmaceuticals.

View company
UCB
HQ
Brussels, BE
Employees
9,000

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company